申请人:Karl Thomae GmbH
公开号:US05006522A1
公开(公告)日:1991-04-09
Novel condensed diazepinone of general formula I are described, ##STR1## wherein B represents one of the divalent groups ##STR2## and X.sup.1, X.sup.2, A.sup.1, A.sup.2 and R.sup.1 to R.sup.10 are as defined in herein useful as vagal pacemakers for treating bradycardia and bradyarrhythmia. The novel diazepinones also have spasmolytic properties on peripheral organs, antiemetic properties and are capable of promoting cerebral blood flow.
描述了一种一般式I的新型缩合二氮杂环酮,其中B代表二价基团之一,X.sup.1、X.sup.2、A.sup.1、A.sup.2和R.sup.1到R.sup.10的定义如本文所述,可用作治疗心动过缓和心动过缓性心律失常的迷走神经节调节器。这种新型二氮杂环酮还具有对外周器官的解痉作用、抗恶心作用,并能促进脑血流。